Esomeprazole and naproxen and Insulin Glargine (U-300) Pens
Determining the interaction of Esomeprazole and naproxen and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esomeprazole / naproxen
Brand name: Vimovo
Synonyms: Naproxen and Esomeprazole
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esomeprazole and naproxen-Insulin glargine and lixisenatide
- Esomeprazole and naproxen-Insulin glargine and lixisenatide Subcutaneous
- Esomeprazole and naproxen-Insulin glargine, recombinant Subcutaneous
- Esomeprazole and naproxen-Insulin glulisine
- Esomeprazole and naproxen-Insulin Glulisine (Cartridges and Pens)
- Esomeprazole and naproxen-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Esomeprazole Capsules
- Insulin Glargine (U-300) Pens-Esomeprazole Delayed-Release Capsules
- Insulin Glargine (U-300) Pens-Esomeprazole Delayed-Release Tablets
- Insulin Glargine (U-300) Pens-Esomeprazole injection
- Insulin Glargine (U-300) Pens-Esomeprazole Magnesium
- Insulin Glargine (U-300) Pens-Esomeprazole Oral, Intravenous